EXELIOM BIOSCIENCES SAS
Business Summary
Exeliom Biosciences SAS, formerly Nextbiotix SAS, is a France-based preclinical-stage biopharmaceutical company. It focuses on probiotics, particularly in microbial therapies for the treatment of patient inflammatory bowel disorders. The lead candidates are based on Faecalibacterium prausnitzii in modulating immune activity in the gut.
Country of Incorporation
France
Incorporation Date
2016-12-12
Business Sector
Pharmaceuticals & Medical Research
Company Address
67 rue des Godrans
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
